UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
Specialized Health Products International, Inc.
------------------------------------------------
(Name of Issuer)
Common Stock
------------------------------
(Title of Class of Securities)
847461100
---------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
13G
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
John T. Clarke
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b)
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
NUMBER OF 5 SOLE VOTING POWER
SHARES 466,000
BENEFICIALLY
OWNED BY 6 SHARED VOTING POWER
EACH 181,306
REPORTING
PERSON 7 SOLE DISPOSITIVE POWER
WITH 466,000
8 SHARED DISPOSITIVE POWER
181,306
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
647,306
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.2%
12 TYPE OF REPORTING PERSON*
IN
<PAGE>
Item 1.
(a) Name of Issuer: Specialized Health Products International, Inc.
(b) Address of Issuer's Principal Executive Office: 655 East Medical Drive,
Bountiful, Utah 84010.
Item 2.
(a) Name of Person Filing: John T. Clarke
(b) Address of Principal Business Office or, if none, Residence:
Thatchetts Camp Road, Gerrards Cross, Buckinghamshire, England
(c) Citizenship: United Kingdom
(d) Title of Class of Securities: Common Stock
(e) CUSIP Number: 847461100
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13(d)-2(b),
check whether the person filing is a:
Not applicable.
Item 4. Ownership
(a) Amount Beneficially Owned: 647,306
(b) Percent of Class: 6.2%
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote 466,000
(ii) shared power to vote or to direct the vote 181,306
(iii) sole power to dispose or to direct the disposition of 466,000
(iv) shared power to dispose or to direct the disposition
of 181,306
Item 5. Ownership of Five Percent or Less of a Class
Not applicable
Item 6. Ownership of More Than Five Percent on Behalf of Another Person
Legal title to 163,306 of the shares reported in Item 4 above are owned by Mr.
Clarke's wife and 18,000 of the shares reported in Item 4 above are owned by Mr.
Clarke's minor child. As a result, Mrs. Clarke and those with authority to make
legal decisions on behalf of Mr. Clark's minor child have the right to receive
or the power to direct the receipt of dividends from, or the proceeds from the
sale of, such securities.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Not applicable
Item 8. Identification and Classification of Members of the Group
Not applicable
Item 9. Notice of dissolution of Group
Not applicable
<PAGE>
Item 10. Certification
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 12, 1998
________________________________
Dated
/s/ John T. Clarke
________________________________
John T. Clarke
